Carl's Law

Bill: 114-hr-5601
Sponsor: full_name: Rep. Kuster, Ann M. [D-NH-2]
Introduced: 2016-06-28
Policy area: Health
Subjects: Consumer affairs

Drug safety, medical device, and laboratory regulation

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Prescription drugs
Latest action: action_date: 2016-06-28
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2016-06-28
action_desc: Introduced in House
text: <p><b>Carl's Law</b></p> This bill amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug containing an opioid to prominently state that the drug contains an opioid and addiction to the drug is possible. (Opioids are drugs with effects similar to opium, such as certain pain medications.)

tv_txt: I 114th CONGRESS 2d Session H. R. 5601 IN THE HOUSE OF REPRESENTATIVES June 28, 2016 Ms. Kuster (for herself and Mr. Walberg ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require the label of any drug containing an opiate to prominently state that addiction is possible.

1. Short title This Act may be cited as the Carl’s Law . 2. Labeling requirement to alert all consumers of opiates that addiction is possible (a) Misbranding Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (dd) If it is a drug containing an opiate (as defined in section 102 of the Controlled Substances Act) unless the label prominently states that the drug contains an opiate and addiction is possible. . (b) Delayed applicability The amendment made by subsection (a) applies beginning on the date that is 180 days after the date of enactment of this Act.